Cellular Therapeutics Limited is a private limited company located at 48 Grafton Street, Manchester M13 9XX. Incorporated on 2017-08-24, this 6-year-old company is run by 2 directors.
Director Robert H., appointed on 19 November 2019. Director Neill M., appointed on 24 August 2017.
The company is officially categorised as "research and experimental development on biotechnology" (SIC: 72110). According to Companies House records there was a name change on 2018-03-29 and their previous name was Immetacyte Limited.
The latest confirmation statement was sent on 2023-08-23 and the due date for the following filing is 2024-09-06. Furthermore, the accounts were filed on 31 August 2022 and the next filing is due on 31 May 2024.
Office Address | 48 Grafton Street |
Town | Manchester |
Post code | M13 9XX |
Country of origin | United Kingdom |
Registration Number | 10931123 |
Date of Incorporation | Thu, 24th Aug 2017 |
Industry | Research and experimental development on biotechnology |
End of financial Year | 31st August |
Company age | 7 years old |
Account next due date | Fri, 31st May 2024 (21 days left) |
Account last made up date | Wed, 31st Aug 2022 |
Next confirmation statement due date | Fri, 6th Sep 2024 (2024-09-06) |
Last confirmation statement dated | Wed, 23rd Aug 2023 |
The list of PSCs that own or have control over the company is made up of 2 names. As we established, there is Immetacyte Limited from Manchester, United Kingdom. The abovementioned PSC is classified as "a private limited company", has 75,01-100% voting rights and has 75,01-100% shares. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares. Another entity in the PSC register is Neill M. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.
Immetacyte Limited
48 Grafton Street, Manchester, M13 9XX, United Kingdom
Legal authority | England And Wales |
Legal form | Private Limited Company |
Country registered | United Kingdom |
Place registered | Companies House |
Registration number | 06709883 |
Notified on | 26 February 2018 |
Ceased on | 19 November 2019 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Neill M.
Notified on | 24 August 2017 |
Ceased on | 26 February 2018 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Immetacyte | March 29, 2018 |
Profit & Loss | |||||
---|---|---|---|---|---|
Accounts Information Date | 2018-08-31 | 2019-08-31 | 2020-08-31 | 2021-08-31 | 2022-08-31 |
Balance Sheet | |||||
Cash Bank On Hand | 0 | 0 | 0 | 0 | 0 |
Net Assets Liabilities | 0 | 0 | 0 | 0 | 0 |
Other | |||||
Number Shares Allotted | 1 | 1 | 1 | 4 | 4 |
Par Value Share | 0 | 0 | 0 | 0 | 0 |
Type | Category | Free download | |
---|---|---|---|
CS01 |
Confirmation statement with no updates 23rd August 2023 filed on: 8th, September 2023 |
confirmation statement | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy